Master Alliance Provisions Guide (MAPGuide)

CSIC – MPP (C-TAP), COVID-19 Diagnostic, Patent & Material License Agreement

  • Protecting & sharing information | Information sharing

11. Considerations and Follow–Up Reports

As consideration for the rights conveyed by CSIC under this Agreement, MPP shall use reasonable efforts to sublicense the rights to develop, use and Commercialize the Patent Rights and Material to companies interested to manufacture and/or Commercialise the Product. MPP will keep CSIC regularly informed of the progress in the search for sublicensees.